N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxamide

Catalog No. :
ACRWGM410
CAS No. :
2246743-13-3
Molecular Formula :
C16H22BNO3
Molecular Weight :
287.17

IUPAC Name:N-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxamide

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$76.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxamide
IUPAC NameN-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxamide
MDL No.MFCD32206433
Molecular FormulaC16H22BNO3
Molecular Weight287.17
SMILESO=C(C1CC1)NC2=CC=CC=C2B3OC(C)(C)C(C)(C)O3
InChI KeyKPCMKCASQACTOR-UHFFFAOYSA-N
SynonymCyclopropanecarboxamide, N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-;N-[2-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropanecarboxamide;N-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropanecarboxamide;N-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxamide - [T71129]
CAS No.2246743-13-3

Synthetic Route by SureRoute

1. ACRWGM410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEBQO029 route compound structure diagram
    ACEBQO029191171-55-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRWGM410 route product structure diagram
    ACRWGM4102246743-13-3
Inquiry

2. ACRWGM410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRWGM410 route product structure diagram
    ACRWGM4102246743-13-3
Inquiry

Comments (0)